SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is drawing attention as crude prices surge amid reported tanker attacks and supply risks around the Strait of Hormuz, alongside concerns about Saudi and Russian energy infrastructure. Traders are split between betting on further gains from geopolitical disruption and warning that prices look extended and could retreat if diplomacy or supply relief eases those fears.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras steep post-IPO slide is being tied by traders to recurring lockup share releases and insider selling, alongside a TD Cowen rating-target cut and concerns about the AI-chip sector. The community is divided between expecting more downside amid valuation, customer-concentration, and scaling concerns, and viewing the selloff as an oversold opportunity based on Cerebras technology and potential demand.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves sharp selloff is being tied mainly to concerns about its heavy debt, financing costs and ability to fund AI infrastructure expansion, amid broader weakness in neocloud stocks. Bears warn of dilution or default, while bulls cite its contracted backlog, Nvidia ties and ARKs buying; the Goldman upgrades failure to sustain a rally underscores the divide.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A tech-led rebound after the recent AI-stock selloff has put QQQ in focus, but traders are divided over whether it marks a recovery or a short-lived relief rally and bull trap. Upcoming megacap earnings and lingering concerns about AI spending and debt, alongside rising oil prices, are adding to the volatility.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Ciphers sharp selloff is being tied mainly to its convertible-note financing and debt conversion, which traders fear will dilute shareholders, alongside broader weakness in AI/data-center stocks and concerns about debt and execution. The community is split between calling the decline an oversold buying opportunity and warning that selling pressure could continue.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStops warrant-expiration deadline dominates discussion, with holders weighing whether the warrants can become exercisable against the risk they expire worthless. Traders disagree over whether the expiration would ease dilution concerns or signal a failed catalyst, while some speculate Ryan Cohen may extend the warrants or take action to lift the share price.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale shares are under pressure after UBS downgraded the stock to Sell, citing lengthy commercialization timelines and a lack of firm customer commitments. The move has sharpened debate over execution risk and cash burn, with some traders viewing the selloff as a buying opportunity while others see limited commercial progress as a reason for caution.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

A sharp selloff across AI infrastructure and neocloud stocks, amid concerns about debt, financing costs, and returns on data-center spending, has driven NBIS discussion. Traders are split on whether the stocks rebound signals stabilization or a bull trap: bulls see Nebius as better positioned than more leveraged peers, while bears remain wary of funding needs and sector-wide risk.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Morgan Stanleys upgrade of Amazon to a top pick, backed by an upbeat outlook for AWS growth and AI infrastructure demand, fueled the sharp share advance. Traders largely welcomed the move, while others questioned whether it would hold and viewed the upcoming earnings report as a key test.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Barclays downgrade of Dell, citing limited evidence of accelerating enterprise AI spending and concerns that higher memory costs are inflating reported revenue, is the main catalyst behind the sharp selloff; broader worries about inflation, rates and AI infrastructure financing added pressure. Traders are split between viewing the decline as an oversold buying opportunity and expecting further weakness after the stocks steep run-up.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers

Liminatus Pharma (NASDAQ:LIMN) stock increased by 48.4% to $0.16 during Thursday's regular session. The market value of their outstanding shares is at $7.2 million.
BeyondSpring (NASDAQ:BYSI) shares movedread more...

Liminatus Pharma Buys More Time, September 3 Deadline is Now the Catalyst

Liminatus Pharma (NASDAQ:LIMN) has cleared one immediate Nasdaq hurdle, but the clock is still running. The company announced that its common stock transferred from the Nasdaq Global Market to the Nasdaq Capital Market effective August 4, 2026, while the Nasdaq Hearings Panel granted Liminatus additional time to regain compliance with the exchange’s minimum bid price requirement. The new deadline is September 3, 2026, giving the company several more weeks to demonstrate compliance while allowing LIMN to continue trading on Nasdaq under its existing ticker.

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers

Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.9% to $0.17 during Thursday's pre-market session. The company's market cap stands at $7.2 million.
LENSAR (NASDAQ:LNSR) shares increased byread more...

Gainers

Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.6% to $0.18 during Thursday's regular session. The company's market cap stands at $7.6 million.
Agape ATP (NASDAQ:ATPC) shares moved upwards byread more...

11 Health Care Stocks Moving In Thursday's Intraday Session

Gainers

Chemomab Therapeutics (NASDAQ:CMMB) stock increased by 33.8% to $2.27 during Thursday's regular session. The market value of their outstanding shares is at $12.2 million.
Liminatus Pharma (NASDAQ:LIMN)read more...

Liminatus Pharma (LIMN) Stock Is Trending Overnight  Here's Why it Spiked Over 30% in After-Hours Session (UPDATED)

Liminatus Pharma shares surged 30.49% in after-hours trading following an amended InnocsAI merger deal that speeds up closing.read more...

The Biotech Repricing Wave May Be Starting as Capital Pours into High-Impact Oncology Platforms

Biotech investors are once again rotating aggressively into clinical-stage growth stories as a fresh wave of capital raises, pipeline expansions, analyst initiations, and oncology breakthroughs reshapes momentum across the sector. $NTHI, $IMMX, $RLAY, $AKTX, $LIMN

Liminatus Pharma Is Trending Overnight  Here's Why LIMN Stock Surged Over 79% In After-Hours Session

Liminatus Pharma Inc. shares soared in after-hours trading after the company announced a merger agreement with InnocsAI LLC.read more...

Liminatus Pharma Stock Surges to Record High After Regaining Nasdaq Compliance 

Equity

The company had previously faced a notice for delayed filings but has since rectified the issue.

Liminatus Pharma, Inc. is a pre-clinical stage biopharmaceutical company, which engages in developing novel, immune-modulating cancer therapies. The company was founded on November 1, 2020 and is headquartered in Cerritos, CA.

Liminatus Pharma Inc. - Ordinary Shares - Class A

Neutral Sentiment

Shares of Liminatus Pharma, Inc. hit a record high on Wednesday after the company declared it had restored compliance with Nasdaq listing standards.The stock closed at $12.71, up 132.8% on Wednesday, with after-hours trading pushing the price further up 69.2% to $21.50.Liminatus received formal confirmation from Nasdaq on June 3, confirming the Nasdaq Listing Rule 5250(c)(1), which requires timely submission of reports to the U.S. Securities and Exchange Commission (SEC).&nbsp;The matter is now considered closed.Earlier on May 29, the company received a notice for not submitting its quarterly report on Form 10-Q for the quarter ended March 31, 2025, promptly.&nbsp;Liminatus submitted the delayed report on June 2, reinstating its SEC reporting compliance.Liminatus came public in early May following a Special Purpose Acquisition Company (SPAC) merger.On Stocktwits, retail sentiment was ‘extremely bullish’ amid ‘extremely high’ message volume.While pointing out that the Liminatus Pharma stock held support, one user said they expected the rally to continue to the next day due to the relatively small float size of 150,000.<stembedurl>https://stocktwits.com/WealthQuest/message/616859995</stembedurl>Another user suggested that the company was preparing to spike to $35.<stembedurl>https://stocktwits.com/View2021/message/616842522</stembedurl>Since its May listing, the stock&nbsp;has risen 9.7% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Generic capsules, 25 July 2004. AFR Picture by LOUIE DOUVIS (Photo by Fairfax Media via Getty Images)

Liminatus Pharma Inc.

$SPCX

$NFLX

$TSLA

$META

Which earnings release are you most looking forward to this week: $SPCX, $NFLX, $TSLA, or $META? Drop a comment for others.

Current Price	$3.11
Prev Close	$3.04
Open	$3.18
Dividend Yield	0.00%
50-Day Moving Average	$4.24
Beta	1.24
Avg. Volume	26,378.59
PE Ratio	-0.14

52-Week High	$141.50
52-Week Low	$3.01
Market Capitalization	$4.08M
EPS (Annual)	-$21.48
Price to Book	11.58
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info

LIMN Fundamentals